NanoLogix Inc (NNLX)

[drugmanrx]

I haven't ignored it, it just more word play.

Two questions.

1)Hmmm stock price at the time of that second update was what 8 to 9 cents when he announce that was one way to pay for expansion. The stock price has been hanging around 7 cents since? Would that cause much significance in additional dilution compared to adding value to the company? A factor really?

Over the coming six months we expect to finance the expansion through a combination of increasing revenue from sales of both product lines and fundraising through our current SEC Regulation D, Rule 506 offering for private placement sales of shares.

2) So did or did not the company have increasing revenue from sales of both product lines? How would a shareholder know with no audited financials?

An excuse not a reason. First update was misleading, it was used just to get a quick bump in stock price.